...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZE Slides Up
6
Jan 08, 2019 03:58PM
5
Jan 08, 2019 04:36PM

Here is direct link to slides for Zenith's Biotech Showcase presentation. Slide 15 for abiraterone progressors indicates that data is through January 3, 2019....hot off the press. Slide 16 for enzalutamide progressors doesn't specify, but I assume is also through Jan 3. 

BDAZ

2
Jan 15, 2019 11:35AM
Share
New Message
Please login to post a reply